NEUROLITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Neurolite, and when can generic versions of Neurolite launch?
Neurolite is a drug marketed by Lantheus Medcl and is included in one NDA.
The generic ingredient in NEUROLITE is technetium tc-99m bicisate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m bicisate kit profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEUROLITE?
- What are the global sales for NEUROLITE?
- What is Average Wholesale Price for NEUROLITE?
Summary for NEUROLITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 20 |
| Drug Prices: | Drug price information for NEUROLITE |
| What excipients (inactive ingredients) are in NEUROLITE? | NEUROLITE excipients list |
| DailyMed Link: | NEUROLITE at DailyMed |
US Patents and Regulatory Information for NEUROLITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lantheus Medcl | NEUROLITE | technetium tc-99m bicisate kit | INJECTABLE;INJECTION | 020256-001 | Nov 23, 1994 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NEUROLITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lantheus Medcl | NEUROLITE | technetium tc-99m bicisate kit | INJECTABLE;INJECTION | 020256-001 | Nov 23, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Lantheus Medcl | NEUROLITE | technetium tc-99m bicisate kit | INJECTABLE;INJECTION | 020256-001 | Nov 23, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NEUROLITE
See the table below for patents covering NEUROLITE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Singapore | 71192 | ⤷ Sign Up | |
| Portugal | 86787 | PROCESSO PARA A PREPARACAO DE ESTERES DERIVADOS DE UM DIAMINODITIOL SUBSTITUIDO E DE COMPOSICOES FARMACEUTICAS RADIOACTIVAS QUE OS CONTEM SOB A FORMA DE COMPLEXOS COM RADIONUCLIDOS | ⤷ Sign Up |
| Ireland | 880431 | ⤷ Sign Up | |
| Israel | 85445 | ⤷ Sign Up | |
| Canada | 1271195 | DIAMINEDITHIOLS A SUBSTITUANTS ESTER ET COMPLEXES RADIOMARQUES DE CEUX-CI (ESTER-SUBSTITUTED DIAMINEDITHIOLS AND RADIOLABELED COMPLEXES THEREOF) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NEUROLITE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1178838 | 300736 | Netherlands | ⤷ Sign Up | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
| 0279417 | 95C0005 | Belgium | ⤷ Sign Up | PRODUCT NAME: DICHLORHYDRATE DE BICISATE; NATIONAL REGISTRATION NO/DATE: 923 IS 16 F 12 19950316; FIRST REGISTRATION: DK DK.R.11. 931008 19931008 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
